Multiple myeloma: open trials in Spain

83 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2024-519498-20-00
A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
Trial Treatment · Phase 1/2 · Cellcentric Limited
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Infanta Leonor, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario de la Princesa, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-05
NCT05137054
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Trial Treatment · Phase 1 · Regeneron Pharmaceuticals
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-11-05
NCT05583617
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Institut Catala d'Oncologia, Badalona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-05
NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitari Mutua Terrassa, Terrassa · Hospital Universitario Dr. Peset Aleixandre, Valencia
Registry updated 2026-11-04
NCT07393282
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Hospital General Universitario Dr. Balmis, Alicante · Institut Catala d'Oncologia, Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital General Universitario Morales Meseguer, Murcia · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Son Llatzer, Palma · Clínica Universidad de navarra, Pamplona · Complejo Asistencial Universitario de Salamanca, Salamanca · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitari Mutua Terrassa, Terrassa · Hospital Universitario Dr. Peset Aleixandre, Valencia · Hospital Universitario Araba, Vitoria
Registry updated 2026-11-04
NCT04634552
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-03
NCT05201781
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Trial Treatment · Phase 4 · Janssen Research & Development, LLC
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-03
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Hospital de Jerez de la Frontera, Jerez de la Frontera · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario HM Sanchinarro, Madrid · University Hospital Son Espases, Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Fundacio Assistencial De Mutua De Terrassa Fpc, Terrassa · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT05652335
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-03
NCT06323447
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Research · Leuko Labs, Inc.
Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-03
NCT07149857
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-03
NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de Galdakao-Usansolo, Galdakao · Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT07589634
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Hosp. de La Santa Creu I Sant Pau, Barcelona · Hosp. de Leon, León · Hosp. Univ. La Paz, Madrid · Hosp. Blua Sanitas Valdebebas, Madrid · Hosp Regional Univ de Malaga, Málaga · Hosp. de Navarra, Pamplona · Hosp. Univ. Dr. Peset, Valencia
Registry updated 2026-11-03
NCT07665450
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hosp. Univ. Germans Trias I Pujol, Badalona · Hosp.Clinic and Provincial, Barcelona · Hosp. de La Santa Creu I Sant Pau, Barcelona · Hosp. San Pedro de Alcantara, Cáceres · Hosp. Univ. Virgen de Las Nieves, Granada · Hosp. de Jerez de La Frontera, Jerez de la Frontera · Hosp. de Leon, León · Hosp. Univ. Lucus Augusti, Lugo · Hosp. Univ. Ramon Y Cajal, Madrid · Hosp. Univ. La Paz, Madrid · Hosp. Univ. Infanta Leonor, Madrid · Hosp. Univ. 12 de Octubre, Madrid · Hosp. Gral. Univ. Gregorio Maranon, Madrid · Hosp. Univ. de La Princesa, Madrid · Complejo Hosp. de Navarra 1, Pamplona · Complejo Hosp. de Navarra, Pamplona · Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcón · Hosp Clinico Univ de Salamanca, Salamanca · Hosp. Univ. Marques de Valdecilla, Santander · Hospital Universitario Virgen Rocio, Seville · Hosp. Univ. Dr. Peset, Valencia · Hosp. Clinico Univ. Lozano Blesa, Zaragoza
Registry updated 2026-11-03
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Barcelona · Barcelona · Cáceres · León · Madrid · Marbella · Marbella · Murcia · Palma · Palma
Registry updated 2026-10-30
NCT06106945
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Trial Treatment · Phase 1/2 · AstraZeneca
Badalona · Madrid · Pamplona · Salamanca
Registry updated 2026-10-30
NCT07284758
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 2 · C4 Therapeutics, Inc.
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario De Leon, León · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Clinica Universidad de Navarra, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-10-30
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Institut Catala d'Oncologia, Badalona · Hospital Universitario Virgen de las Nieves, Granada · Clinica Universidad de Navarra, Madrid · University Hospital Son Espases, Palma · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-10-29
NCT07901868
Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 2 · PETHEMA Foundation
Complejo Hospitalario de Albacete, Albacete · Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitari Germans Trias i Pujol (ICO Badalona), Badalona · H. Moises Broggi, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de Cabuenes, Gijón · H. Un. Virgen de las Nieves, Granada · C. H. U. de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria · Complejo Hospitalario Lucus Augusti, Lugo · Hospital Doce de Octubre, Madrid · C. H. Gregorio Marañón, Madrid · Complejo Hospital Costa Del Sol (Ivcs), Málaga · H. Un. Virgen de la Arrixaca, Murcia · Hospital Central de Asturias, Oviedo · Hospital Son Llàtzer, Palma de Mallorca · Clinica Universidad de Navarra (CUN), Pamplona · Hospital Clinico Universitario Salamanca, Salamanca · H. Universitario Marqués de Valdecilla, Santander · Hospital Universitari i Politécnic La Fe, Valencia · H. U. Txagorritxu, Vitoria-Gasteiz
Registry updated 2026-10-28
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Institut Català d'Oncologia, Girona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Regional de Málaga, Málaga · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitari Mutua Terrassa, Terrassa · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Universitario Dr. Peset Aleixandre, Valencia
Registry updated 2026-10-27
NCT03761108
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-10-26
NCT04973605
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Trial Treatment · Phase 1/2 · BeOne Medicines
Hospital Clinic de Barcelona, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario Virgen de la Victoria, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-10-26
NCT05651932
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Trial Treatment · Phase 1 · K36 Therapeutics, Inc.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · University Clinic of Navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-10-22
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Trial Treatment · Phase 3 · AstraZeneca
Badalona · Barcelona · El Palmar · Madrid · Salamanca · Santander · Seville
Registry updated 2026-10-21
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 1 · Genentech, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid
Registry updated 2026-10-20

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error